COVID-19 Updates
From the Journals
Cardiac issues twice as likely with COVID plus high troponin
Hospitalized COVID-19 patients with high troponin levels were twice as likely to have cardiac abnormalities due to diverse causes in a large U.K....
News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.
From the Journals
Prehospital COVID therapy effective in rheumatic disease patients
Patients with rheumatic disease and SARS-CoV-2 infection who received outpatient treatment fared better than similar patients who did not receive...
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”
Commentary
The five biggest changes in the 2023 adult vaccine schedules
COVID vaccines are now front and center among 2023’s five most important changes.
Commentary
A new (old) drug joins the COVID fray, and guess what? It works
Part of the reason the monoclonals have failed lately is because of their specificity.
From the Journals
Maternal COVID-19 vaccine curbs infant infection
Maternal mRNA COVID-19 vaccination during pregnancy was less effective in protecting infants against omicron.
From the Journals
Keeping physician stress in check
Physician stress is in part due to systemic institutional challenges, but coping strategies can help.
From the Journals
Acute cardiac events common during COVID hospitalization
“We expected to see acute cardiac events occurring among adults hospitalized with COVID-19 but were surprised by how frequently they occurred.”
Highlights
New developments and barriers to palliative care
The need for palliative care in the United States is projected to grow significantly in the next decades.
Feature
More data back Guillain-Barré risk with Janssen COVID shot
Observed GBS cases after the Janssen shot were 2 to 3 times greater than expected, based on background rates within 21 and 42 days of vaccination...